Fig. 5: The nonspecific antiviral effect of Fe2 DAC and application in air filter for the inactivation of airborne flu virus.
From: Diatomic iron nanozyme with lipoxidase-like activity for efficient inactivation of enveloped virus
a HA titer of Fe2 DAC-treated H1N1 (purified virus) IAVs, under 15/30/60/90 min. b HA titer of Fe2 DAC-treated H1N1 (purified virus) IAVs at 37 °C and 4 °C, under 90 min. c HA titer of Fe2 DAC-treated H9N2 (purified virus) IAVs, under 15/30/60/120 min. d HA titer of H1N1 IAVs treated with Fe2 DAC coated nonwoven HEPA filter, under 90 min. All the data are presented as means ± SD (n = 3 independent measurements). The significant difference was evaluated by a two-tailed unpaired t test. *p < 0.05 and **p < 0.01.
